5-10 million to manufacture radiogel to "hopefully create" a market sounds like risky. Especially with AMIC'S track record.
Before they spend 5-10 million to get into a market that BARELY exists, they should try getting a real fda approval and do the suggested clinical trials so that the 5-10 million can get amic rolling on an existing market to get their feet wet. Maybe after they get any sort of revenues coming in would be a much better time to take on the high risk of animal branchyotherapy.